MA
Mamraj Agrawal
About Mamraj Agrawal
Data last updated:
Mamraj Agrawal has 18 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Singhvi Medicare And Research Centre Pvt. Ltd. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Singhvi Medicare And Research Centre Pvt. Ltd at ₹22.12 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Singhvi Medicare And Research Centre Pvt. Ltd U85110RJ1989PTC005188 | Additional Director | 18 Feb 2008 | 1989 | ₹22.12 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mamraj Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mamraj Agrawal
Mamraj Agrawal has 18 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Singhvi Medicare And Research Centre Pvt. Ltd. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Singhvi Medicare And Research Centre Pvt. Ltd at ₹22.12 Cr (FY 2025).
Mamraj Agrawal is associated with 1 company as Additional Director, including Singhvi Medicare And Research Centre Pvt. Ltd (₹22.12 Cr).
Mamraj Agrawal has expertise in General Business.
Mamraj Agrawal has 18 years in corporate governance.
By reported revenue, the largest current company of Mamraj Agrawal is Singhvi Medicare And Research Centre Pvt. Ltd, with revenue of ₹22.12 Cr (FY 2025).
Mamraj Agrawal currently holds positions at 1 company: Singhvi Medicare And Research Centre Pvt. Ltd (₹22.12 Cr).